These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

122 related articles for article (PubMed ID: 3102725)

  • 41. Next Generation Gold Drugs and Probes: Chemistry and Biomedical Applications.
    Mertens RT; Gukathasan S; Arojojoye AS; Olelewe C; Awuah SG
    Chem Rev; 2023 May; 123(10):6612-6667. PubMed ID: 37071737
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Inhibition of production of macrophage-derived angiogenic activity by the anti-rheumatic agents gold sodium thiomalate and auranofin.
    Koch AE; Cho M; Burrows J; Leibovich SJ; Polverini PJ
    Biochem Biophys Res Commun; 1988 Jul; 154(1):205-12. PubMed ID: 2456062
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Auranofin, gold thiomalate, and gold thioglucose inhibit protein kinase C.
    Mahoney CW; Hensey CE; Azzi A
    Biochem Pharmacol; 1989 Oct; 38(19):3383-6. PubMed ID: 2510733
    [No Abstract]   [Full Text] [Related]  

  • 44. Inhibitory effects of gold sodium thiomalate on DNA polymerase alpha.
    Takeuchi F; Hanaoka F; Matsuta K; Miyamoto T
    Clin Exp Rheumatol; 1989; 7(6):595-601. PubMed ID: 2515017
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Do gold drugs inhibit interleukin-1? Evidence from an in vitro lymphocyte activating factor assay.
    Haynes DR; Garrett IR; Whitehouse MW; Vernon-Roberts B
    J Rheumatol; 1988; 15(5):775-8. PubMed ID: 3139878
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Gold therapy in rheumatoid arthritis. Interim report of the Canadian multicenter prospective trial comparing sodium aurothiomalate and auranofin.
    Menard HA; Beaudet F; Davis P; Harth M; Percy JS; Russell AS; Thompson JM
    J Rheumatol Suppl; 1982; 8():179-83. PubMed ID: 6813482
    [TBL] [Abstract][Full Text] [Related]  

  • 47. The effect of gold sodium thiomalate and auranofin on lipopolysaccharide-induced interleukin-1 production by blood monocytes in vitro: variation in healthy subjects and patients with arthritis.
    Danis VA; Kulesz AJ; Nelson DS; Brooks PM
    Clin Exp Immunol; 1990 Mar; 79(3):335-40. PubMed ID: 2107989
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Scarring alopecia following gold therapy.
    Burrows NP; Grant JW; Crisp AJ; Roberts SO
    Acta Derm Venereol; 1994 Nov; 74(6):486. PubMed ID: 7701895
    [No Abstract]   [Full Text] [Related]  

  • 49. [Experiences to date with oral gold therapy].
    Zeidler H
    Wien Klin Wochenschr Suppl; 1984; 156():22-7. PubMed ID: 6442052
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Treatment of psoriatic arthritis with auranofin and gold sodium thiomalate.
    Brückle W; Dexel T; Grasedyck K; Schattenkirchner M
    Clin Rheumatol; 1994 Jun; 13(2):209-16. PubMed ID: 8088061
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Induction of stress proteins in mouse peritoneal macrophages by the anti-rheumatic agents gold sodium thiomalate and auranofin.
    Sato H; Yamaguchi M; Shibasaki T; Ishii T; Bannai S
    Biochem Pharmacol; 1995 May; 49(10):1453-7. PubMed ID: 7763288
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Adverse reactions to gold compounds.
    Cohen MA
    Adverse Drug React Acute Poisoning Rev; 1988; 7(4):163-78. PubMed ID: 3149142
    [No Abstract]   [Full Text] [Related]  

  • 53. [Possible mechanism of action of drugs in the basic therapy of rheumatoid arthritis: effect on platelet aggregation].
    Fioravanti A; Lolatte V; Giordano N; Frati E; Castagna ML; Morozzi G; Lalumera M; Marcolongo R
    Boll Soc Ital Biol Sper; 1984 May; 60(5):1051-6. PubMed ID: 6432005
    [TBL] [Abstract][Full Text] [Related]  

  • 54. [Effects of gold compounds on lymphocyte transformation and neutrophil chemotaxis--a comparison between sodium aurothiomalate and auranofin].
    Negishi M; Sato H; Sekine F; Ohno I; Kobayashi K; Ohseto Y; Hamai T; Takahashi T
    Ryumachi; 1983 Jun; 23(3):163-7. PubMed ID: 6414094
    [No Abstract]   [Full Text] [Related]  

  • 55. A three year follow up of patients allocated to placebo, or oral or injectable gold therapy for rheumatoid arthritis.
    Capell HA; Lewis D; Carey J
    Ann Rheum Dis; 1986 Sep; 45(9):705-11. PubMed ID: 3094463
    [TBL] [Abstract][Full Text] [Related]  

  • 56. The effects of anti-arthritic gold compounds on mycoplasma and leishmania.
    Berkoff CE; Actor P; Sutton BM; Walz DT; Klinikowski N
    Arzneimittelforschung; 1974 Dec; 24(12):1988-90. PubMed ID: 4217631
    [No Abstract]   [Full Text] [Related]  

  • 57. Effect of metal complexes on thioredoxin reductase and the regulation of mitochondrial permeability conditions.
    Bragadin M; Scutari G; Folda A; Bindoli A; Rigobello MP
    Ann N Y Acad Sci; 2004 Dec; 1030():348-54. PubMed ID: 15659816
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Inhibition of human endothelial cell proliferation by gold compounds.
    Matsubara T; Ziff M
    J Clin Invest; 1987 May; 79(5):1440-6. PubMed ID: 3106416
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Inhibition of human neutrophil collagenase by gold(I) salts used in chrysotherapy.
    Mallya SK; Van Wart HE
    Biochem Biophys Res Commun; 1987 Apr; 144(1):101-8. PubMed ID: 3034241
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Long-term efficacy and safety of auranofin: a review of clinical experience.
    Blodgett RC; Pietrusko RG
    Scand J Rheumatol Suppl; 1986; 63():67-78. PubMed ID: 3110943
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.